{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:07:51Z","timestamp":1784099271836,"version":"3.55.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13217","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:17:57Z","timestamp":1782217077000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Recovery from severe adriamycin\u2011induced cardiomyopathy after prolonged intensive care in a patient with uterine leiomyosarcoma: A case report"],"prefix":"10.3892","volume":"32","author":[{"given":"Kohei","family":"Tamura","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Koyanagi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Shirasu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Suizu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Taneichi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Saga","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jichi Medical University Hospital, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20110498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"key20260715092755_b1-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"key20260715092755_b2-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/annonc\/mdl397","article-title":"ABVD for Hodgkin's lymphoma: Full-dose chemotherapy without dose reductions or growth factors","volume":"18","author":"Boleti","year":"2007","journal-title":"Ann Oncol"},{"key":"key20260715092755_b3-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","article-title":"Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer","volume":"24","author":"Jones","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20260715092755_b4-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20260715092755_b5-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamaoncol.2019.0001","article-title":"Effect of taxane plus platinum regimens vs doxorubicin plus cisplatin as adjuvant chemotherapy for endometrial cancer at a high risk of progression: A Randomized clinical trial","volume":"5","author":"Nomura","year":"2019","journal-title":"JAMA Oncol"},{"key":"key20260715092755_b6-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1470-2045(22)00380-1","article-title":"Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): A Randomised, multicentre, open-label phase 3 trial","volume":"23","author":"Pautier","year":"2022","journal-title":"Lancet Oncol"},{"key":"key20260715092755_b7-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"key20260715092755_b8-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"key20260715092755_b9-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"key20260715092755_b10-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key20260715092755_b11-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"key20260715092755_b12-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"key":"key20260715092755_b13-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/MCC.0000000000000838","article-title":"Hemodynamic monitoring in cardiogenic shock","volume":"27","author":"VanDyck","year":"2021","journal-title":"Curr Opin Crit Care"},{"key":"key20260715092755_b14-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1200\/JCO.2008.19.8366","article-title":"Stage-specific outcomes of patients with uterine leiomyosarcoma: A comparison of the International Federation of gynecology and obstetrics and American joint committee on cancer staging systems","volume":"27","author":"Zivanovic","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20260715092755_b15-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"key20260715092755_b16-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1161\/CIR.0000000000001062","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"key20260715092755_b17-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"26","key":"key20260715092755_b18-ETM-32-2-13217","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"key20260715092755_b19-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"key20260715092755_b20-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"key20260715092755_b21-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"key20260715092755_b22-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.healun.2008.10.002","article-title":"Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device","volume":"28","author":"Freilich","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"key20260715092755_b23-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1002\/ehf2.13362","article-title":"Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation","volume":"8","author":"Guha","year":"2021","journal-title":"ESC Heart Fail"},{"key":"key20260715092755_b24-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"key20260715092755_b25-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review","volume":"63 (25 Pt A)","author":"Thavendiranathan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key20260715092755_b26-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.clon.2022.05.001","article-title":"Global longitudinal strain for the early detection of chemotherapy-induced cardiotoxicity: A systematic review and meta-analysis","volume":"34","author":"Cocco","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20260715092755_b27-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5935\/abc.20180021","article-title":"Global longitudinal strain accuracy for cardiotoxicity prediction in a cohort of breast cancer patients during anthracycline and\/or trastuzumab treatment","volume":"110","author":"Gripp","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"key20260715092755_b28-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"key20260715092755_b29-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am J Cardiol"},{"key":"key20260715092755_b30-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ejhf.8","article-title":"Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy","volume":"16","author":"Kang","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"key20260715092755_b31-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"key20260715092755_b32-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"key20260715092755_b33-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/emj.2007.050419","article-title":"Morphine and outcomes in acute decompensated heart failure: An ADHERE analysis","volume":"25","author":"Peacock","year":"2008","journal-title":"Emerg Med J"},{"key":"key20260715092755_b34-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.chest.2017.03.037","article-title":"Morphine use in the ED and outcomes of patients with acute heart failure: A propensity score-matching analysis based on the EAHFE registry","volume":"152","author":"Mir\u00f3","year":"2017","journal-title":"Chest"},{"issue":"17539447221087587","key":"key20260715092755_b35-ETM-32-2-13217","doi-asserted-by":"publisher","DOI":"10.1177\/17539447221087587","article-title":"Impact of morphine use in acute cardiogenic pulmonary oedema on mortality outcomes: A systematic review and meta-analysis","volume":"16","author":"Witharana","year":"2022","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"key20260715092755_b36-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"814","DOI":"10.7326\/0003-4819-106-6-814","article-title":"Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases","volume":"106","author":"Saini","year":"1987","journal-title":"Ann Intern Med"},{"key":"key20260715092755_b37-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"key20260715092755_b38-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"key20260715092755_b39-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"key20260715092755_b40-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"903719","key":"key20260715092755_b41-ETM-32-2-13217","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.903719","article-title":"Cardiac MRI assessment of anthracycline-induced cardiotoxicity","volume":"9","author":"Mabudian","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"key20260715092755_b42-ETM-32-2-13217","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.cardfail.2024.12.012","article-title":"Recovery of left ventricular ejection fraction in patients with anthracycline-induced cardiomyopathy: A contemporary cohort study","volume":"31","author":"Itzhaki Ben Zadok","year":"2025","journal-title":"J Card Fail"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:28:02Z","timestamp":1784096882000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13217","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}